enVVeno Medical Corp financial data

Symbol
NVNO on Nasdaq, NVNBW on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
70 Doppler, Irvine, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Hancock Jaffe Laboratories, Inc. (to 9/22/2021)
Latest financial report
10-K/A - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.34K % +12.7%
Debt-to-equity 6.37 % -24.9%
Return On Equity -51.2 % +27%
Return On Assets -48.2 % +25.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.5M shares +31.7%
Common Stock, Shares, Outstanding 17.5M shares +31.7%
Entity Public Float 68.9M USD +136%
Weighted Average Number of Shares Outstanding, Basic 17.1M shares +39.4%
Weighted Average Number of Shares Outstanding, Diluted 17.1M shares +39.4%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 12.2M USD -9.82%
Operating Income (Loss) -23.8M USD +5.6%
Nonoperating Income (Expense) 2.01M USD +16.6%
Net Income (Loss) Attributable to Parent -21.8M USD +7.22%
Earnings Per Share, Basic -1.27 USD/shares +33.5%
Earnings Per Share, Diluted -1.27 USD/shares +33.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.75M USD -51.5%
Assets, Current 43.7M USD -6.8%
Property, Plant and Equipment, Net 182K USD -45.5%
Operating Lease, Right-of-Use Asset 1.01M USD -25.2%
Assets 45M USD -7.57%
Accounts Payable, Current 1.7M USD +239%
Liabilities, Current 2.1M USD +52.8%
Operating Lease, Liability, Noncurrent 700K USD -34.2%
Liabilities 2.8M USD +14.8%
Retained Earnings (Accumulated Deficit) -152M USD -16.8%
Stockholders' Equity Attributable to Parent 42.2M USD -8.75%
Liabilities and Equity 45M USD -7.57%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.55M USD +30.5%
Net Cash Provided by (Used in) Financing Activities 46K USD
Net Cash Provided by (Used in) Investing Activities 2.2M USD -22.3%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 17.5M shares +31.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.31M USD +42.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 45K USD +800%
Deferred Tax Assets, Gross 30.6M USD +20.4%
Operating Lease, Liability 1.06M USD -24.1%
Depreciation 100K USD 0%
Payments to Acquire Property, Plant, and Equipment 10K USD +100%
Lessee, Operating Lease, Liability, to be Paid 1.13M USD -25.6%
Property, Plant and Equipment, Gross 1.44M USD +2.57%
Operating Lease, Liability, Current 364K USD +7.69%
Lessee, Operating Lease, Liability, to be Paid, Year Two 411K USD +3.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 399K USD +3.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 61K USD -44.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 315K USD -23.4%
Deferred Tax Assets, Operating Loss Carryforwards 22.2M USD +28.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 315K USD -23.4%
Additional Paid in Capital 194M USD +10.1%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 30.3M USD +21.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%